ArticleEClinicalMedicine2020
Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions.
Article in EClinicalMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
103 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- From economic burden to patient-centered solutions: the evolving landscape of financial toxicity in oncology.Frontiers in public health · 2026Pooled it
- Subjective and objective financial toxicity among colorectal cancer patients: a systematic review.BMC cancer · 2024Pooled it
- Describing financial toxicity among cancer patients in different income countries: a systematic review and meta-analysis.Frontiers in public health · 2023Pooled it
- Predictors of treatment refusal in patients with colorectal cancer: A systematic review.Seminars in oncology · 2022Pooled it
- Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Pooled it
- A review of Leila Rose Foundation support for families affected by rare childhood cancer in Australia over the past decade.Cancer reports (Hoboken, N.J.) · 2022Pooled it
- Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA).BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2021Trial
- Cost-effectiveness analysis of durvalumab combined with tremelimumab versus sorafenib as first-line treatment for unresectable Hepatocellular carcinoma in China: a dual-model approach utilizing partitioned survival and markov models.BMC gastroenterology · 2026Article
- Financial toxicity among adult cancer survivors in Singapore: does it exist?Singapore medical journal · 2026Article
- Financial toxicity in insured cancer patients: association with global health status in a prospective Brazilian Cohort.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Observational
- Artificial intelligence and transforming cancer care.Discover oncology · 2026Review
- Lung cancer care pathways and journeys: insights from patients at the National Cancer Institute in Mexico.BMC global and public health · 2026Article
- Personalized risk prediction of financial toxicity in patients with cancer: an interpretable machine learning study.JNCI cancer spectrum · 2026Article
- Mediating Role of Family Resilience and Avoidance Between Financial Toxicity and Quality of Life in Cancer Patients: A Cross-Sectional Study.Patient preference and adherence · 2026Article
- Glycemic control and association with diabetes-related distress, self-management behavior, financial toxicity, and cost-related non-adherence: a mixed-methods study.Frontiers in endocrinology · 2026Article
- Large language models for breast cancer treatment planning: a blinded real-world evaluation of DeepSeek, ChatGPT, and oncologist recommendations.Frontiers in digital health · 2026Article
- The impact of risk information frameworks on cancer drug insurance (CDI) purchase decisions through time orientation and perceived risk: a survey-experiment study.Frontiers in public health · 2026Article
- Association of Financial Distress With Nonmedical Out-of-Pocket Expenses in Those With Critical Illness.Hospital pediatrics · 2025Article
- Financial difficulty among patients with cancer participating in clinical trials and its association with patient survival and quality of life.Journal of the National Cancer Institute · 2025Article
- Health disparities in neurology.Nature reviews. Neurology · 2025Review
43 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.